These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 10727043)

  • 21. Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.
    Wallaschofski H; Saller B; Spilcke-Liss E; Lerch MM; Lohmann T; Eigenthaler M
    Horm Metab Res; 2006 Oct; 38(10):656-61. PubMed ID: 17075774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The causes of the end of growth hormone treatment in children with chronic renal failure].
    Leszczyńiska B; Ziółkowska H; Majcher A; Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():153-5. PubMed ID: 16898517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
    Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
    Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optimal time for the administration of rhGH in severely burned patients--analysis of the dynamic changes of IGF axis and blood sugar].
    Han CM; Xie WG; Xu RF; Chen GX
    Zhonghua Shao Shang Za Zhi; 2003 Aug; 19(4):213-5. PubMed ID: 14514400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children.
    Jeschke MG; Finnerty CC; Kulp GA; Przkora R; Mlcak RP; Herndon DN
    Pediatr Crit Care Med; 2008 Mar; 9(2):209-16. PubMed ID: 18477935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of recombinant human growth hormone in children with thalassemia.
    Geffner ME; Karlsson H
    Horm Res; 2009 Jan; 71 Suppl 1():46-50. PubMed ID: 19153505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic growth hormone deficiency testing practices among patients in the NCGS/NCSS databases.
    Levy RA; Connelly K
    J Pediatr Endocrinol Metab; 2003 May; 16 Suppl 3():619-24. PubMed ID: 12795363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
    Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
    J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
    Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.
    Giavoli C; Cappiello V; Corbetta S; Ronchi CL; Morpurgo PS; Ferrante E; Beck-Peccoz P; Spada A
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):81-7. PubMed ID: 15212648
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is GH therapy useful to preserve bone mass in transition-phase patients with GH deficiency?
    Aimaretti G; Corneli G; Rovere S; Croce CG; Ghigo E; Procopio M
    J Endocrinol Invest; 2005; 28(10 Suppl):28-32. PubMed ID: 16550719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effects of recombinant human growth hormone (rhGH) on the serum levels of cytokines in severely burned patients].
    Liang Z; Liu X; Li J; Huo L; Liang D
    Zhonghua Shao Shang Za Zhi; 2002 Feb; 18(1):49-51. PubMed ID: 12515670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone treatment in chronic heart failure: lessons from the first 99 patients.
    Cicoira M; Coats AJ; Anker SD
    Eur Heart J; 1998 Nov; 19(11):1605-7. PubMed ID: 9857911
    [No Abstract]   [Full Text] [Related]  

  • 35. Short-term growth hormone treatment and microcirculation: effects in patients with chronic kidney disease.
    Nissel R; Fischer DC; Puhlmann A; Holdt-Lehmann B; Mitzner A; Petzsch M; Körber T; Tiess M; Schmidt R; Haffner D
    Microvasc Res; 2009 Sep; 78(2):246-52. PubMed ID: 19500600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone as additional treatment for patients with chronic congestive heart failure: a review.
    Bergh CH
    Growth Horm IGF Res; 1998 Apr; 8 Suppl B():171-3. PubMed ID: 10990157
    [No Abstract]   [Full Text] [Related]  

  • 37. [Growth hormone--a pathogenetic factor in chronic congestive heart failure?].
    Dreifuss PM
    Dtsch Med Wochenschr; 1996 Oct; 121(41):1279. PubMed ID: 8925768
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recommendations for the indications for growth hormone substitution in adult age groups. Working group for pituitary gland and pituitary tumors of the German Society for Endocrinology].
    Oertel H; Strasburger CJ; Kann P; Quabbe HJ
    Dtsch Med Wochenschr; 1998 Jul; 123(28-29):883-6. PubMed ID: 9693660
    [No Abstract]   [Full Text] [Related]  

  • 39. [Growth hormone--a pathogenetic factor in chronic congestive heart failure?].
    Hofbauer LC; Heufelder AE
    Dtsch Med Wochenschr; 1996 Aug; 121(34-35):1074. PubMed ID: 8829913
    [No Abstract]   [Full Text] [Related]  

  • 40. Haemodynamic effects of intravenous growth hormone in congestive heart failure.
    Volterrani M; Desenzani P; Lorusso R; d'Aloia A; Manelli F; Giustina A
    Lancet; 1997 Apr; 349(9058):1067-8. PubMed ID: 9107247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.